AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 47 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 2.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $92 | – | 102 | -82.5% | 0.00% | – |
| Q3 2022 | $0 | – | 584 | -18.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 712 | -84.5% | 0.00% | – |
| Q1 2022 | $12,000 | -91.5% | 4,582 | -87.4% | 0.00% | – |
| Q4 2021 | $141,000 | +327.3% | 36,371 | +381.3% | 0.00% | – |
| Q3 2021 | $33,000 | -71.1% | 7,557 | -73.7% | 0.00% | – |
| Q2 2021 | $114,000 | -42.1% | 28,728 | -24.2% | 0.00% | – |
| Q1 2021 | $197,000 | +65.5% | 37,879 | +69.5% | 0.00% | – |
| Q4 2020 | $119,000 | -39.9% | 22,345 | -45.2% | 0.00% | – |
| Q3 2020 | $198,000 | -19.2% | 40,751 | -19.4% | 0.00% | – |
| Q2 2020 | $245,000 | +329.8% | 50,550 | +95.1% | 0.00% | – |
| Q1 2020 | $57,000 | -62.7% | 25,906 | -1.3% | 0.00% | – |
| Q4 2019 | $153,000 | +173.2% | 26,243 | +97.2% | 0.00% | – |
| Q2 2019 | $56,000 | +86.7% | 13,307 | +204.3% | 0.00% | – |
| Q1 2019 | $30,000 | -40.0% | 4,373 | -45.6% | 0.00% | – |
| Q4 2018 | $50,000 | +455.6% | 8,033 | +1532.7% | 0.00% | – |
| Q3 2018 | $9,000 | – | 492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
| Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
| Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
| XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
| ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
| Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
| D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |